Press Releases

New Lyphochek® Allergen sIgE Controls

HERCULES, CA – August 1, 2015 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced the release of human-serum based Lyphochek® Allergen sIgE quality controls to monitor precision of in vitro allergy test procedures.

 

Bio-Rad Laboratories announces the launch of Liquichek Maternal Serum 1st Trimester Control

HERCULES, CA – November, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announces the launch of Liquichek™ Maternal Serum 1st Trimester Control.

 

Bio-Rad Laboratories Expands Their EQAS Offering with Three New Programs

HERCULES, CA – January 11, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announces the release of three External Quality Assurance Service (EQAS®) Programs for clinical laboratories and near patient/POC settings around the world. The new programs are: Cardiac Markers, Ethanol/Ammonia, and Lipids.

 

Bio-Rad Introduces EQAS Mobile, an Easy Way for Clinical Labs to Submit Proficiency Testing Results Using a Smartphone

HERCULES, CA – January 10, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the launch of its EQAS® Mobile (External Quality Assurance Service) that offers clinical laboratories the ability to use an iPhone® or Android™ smartphone to configure and submit their proficiency testing results to Bio-Rad’s QCNet™ online portal (www.QCNet.com/eqasonline).

 

Bio-Rad Laboratories launches the EQAS Coagulation Program

HERCULES, CA – October 25, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the release of External Quality Assurance Service (EQAS) Coagulation Program for clinical laboratories around the world.

 

Bio-Rad Laboratories launches the EQAS Blood Gas Program

HERCULES, CA – October 25, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products today announced the release of its External Quality Assurance Service (EQAS) Blood Gas Program.

 

Bio-Rad Introduces Liquichek Whole Blood Immunosuppressant Control

HERCULES, CA – October 17, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announces the release of Liquichek™ Whole Blood Immunosuppressant Control. This third party, human whole blood based product is designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug testing procedures in the clinical laboratory. Its liquid formulation is suitable for use with immunoassay and chromatographic techniques.

 

Siemens and Bio-Rad Extend Joint Marketing Agreement for IMMULITE and Dimension Systems to Further Optimize Efficiency and Data Reliability

Tarrytown, NY and Hercules, Calif., December 13, 2011 – Today, Siemens Healthcare Diagnostics and
Bio-Rad Laboratories, Inc. announced an expansion of a global joint marketing agreement in which
Bio-Rad will provide its quality control (QC) products and Unity™ data management solutions for Siemens' IMMULITE® Immunoassay, Dimension® Integrated Chemistry and Dimension Vista® Intelligent Lab systems. This move extends clinical laboratories' access to Bio-Rad's consistent control product and data management tools within the Siemens clinical laboratory systems portfolio which, until today, were only available through Siemens' ADVIA® Chemistry and ADVIA Centaur® Immunoassay systems.

 

Bio-Rad Introduces New And Improved Liquichek™ Specialty Immunoassay Control

HERCULES, CA – October 15, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of the enhanced Liquichek™ Specialty Immunoassay Control.

 

Bio-Rad launches elnserts™ XML, an innovative solution to load assay values directly into instruments

HERCULES, CA – May 17, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, today announced the launch of eInserts™ XML, an online service which allows laboratories to generate an XML file with assay values for Bio-Rad quality control products and import the data directly into their instruments.

 

Bio-Rad Introduces Liquichek Opiate Control

HERCULES, CA – April 12, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Opiate Control. Liquichek Opiate Control is a liquid, third party control designed to monitor urine toxicology testing procedures for a broad class of opioids.

 

Bio-Rad Introduces Liquichek Hematology and Reticulocyte Controls for Sysmex Hematology Instruments

HERCULES, CA – March 22, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Hematology Control (X) and Liquichek™ Reticulocyte Control (X). The two products are the latest additions to the growing family of hematology controls from Bio-Rad and are designed to monitor the precision of hematology parameters on Sysmex systems.

 

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Abbott CELL-DYN Sapphire and CELL-DYN 4000 Instruments

HERCULES, CA – February 22, 2009 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Hematology Control (A-I) and Liquichek™ Reticulocyte Control (A-I). These two new products are designed to monitor the precision of hematology parameters on Abbott CELL-DYN® Sapphire and CELL-DYN 4000 systems.

 

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Siemens ADVIA Instruments

HERCULES, CA – January 26, 2009 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Hematology Control (S) and Liquichek Reticulocyte Control (S). These two new products are designed to monitor the precision of hematology parameters on Siemens ADVIA® systems.

 

Find Products & Information

Log In / Register

Log In / Register
PLEASE LOG IN NOT REGISTERED?
Login ID
Password